Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-05-23
2009-11-17
Goddard, Laura B (Department: 1642)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C424S185100, C424S192100
Reexamination Certificate
active
07618936
ABSTRACT:
This invention provides compositions, methods and kits for the diagnosis and treatment of cancers wherein Wnt Inhibitory Factor-1 (WIF-1) is underexpressed.
REFERENCES:
patent: 6844422 (2005-01-01), Niehrs et al.
patent: 2002/0192216 (2002-12-01), Lamb et al.
patent: 2003/0040051 (2003-02-01), Bhanot et al.
patent: 2004/0126359 (2004-07-01), Lamb et al.
patent: 2004/0171153 (2004-09-01), Andrews et al.
patent: 2005/0049195 (2005-03-01), Zou
patent: 1489168 (2004-12-01), None
patent: 9913350.6 (1999-06-01), None
patent: WO 97/39357 (1997-10-01), None
patent: WO 99/22000 (1999-05-01), None
patent: WO 00/74706 (2000-12-01), None
patent: WO 02/077204 (2002-10-01), None
patent: WO 02/080952 (2002-10-01), None
patent: WO 02/090992 (2002-11-01), None
patent: WO 2004/058949 (2003-12-01), None
patent: WO 2004/026908 (2004-04-01), None
patent: WO 2004/058949 (2004-07-01), None
Bowie et al (Science, 1990, 247:1306-1310).
Freshney (Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., 1983, New York, p. 4).
Dermer (Bio/Technology, 1994, 12:320).
Taniguchi et al, Oncogene 2005, 24:7946-7952.
Lin et al (Human Gene Therapy, 2007, 18:379 abstract only).
He, Biao et al.; “A Monoclonal Antibody against Wnt-1 Induces Apoptosis in Human Cancer Cells”; 2004,Neoplasia, vol. 6, No. 1, pp. 7-14.
Hsieh, Jen-Chih et al.; “A new secreted protein that binds to Wnt proteins and inhibits their activites”; 1999,Nature, vol. 398, pp. 431-436.
Wissmann, Christoph et al.; “WIFI, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer”; 2003,J. Pathol., vol. 201, pp. 204-212.
He Biao et al, “Blockade of Wnt-1 signaling induces adoptosis in human colorectal cancer cells containing downstream mutations”, Oncogene, vol. 24, No. 18, Apr. 18, 2005, pp. 3054-3058, XP002470043, ISSN:0950-9232.
Laird PW, “The Power and The Promise of DNA Methylation Markers”, Nature Reviews. Cancer, Nature Publishing Group, London, GB, Vol. 3, No. 4, Apr. 2003, pp. 253-266, XP009044309, ISSN: 1474-175X.
Mazieres J et al, “Wnt signaling in ling cancer”, Cancer Letters, New York, NY, US, vol. 222, No. 1, May 10, 2005, pp. 1-10, XP004856230, ISSN: 0304-3835.
Cebrat, Malgorzata et al.; “Wnt inhibitory factor-1: a candidate for a new player in tumorigenesis of intestinal epithelial cells”; 2004, Cancer Letters, vol. 206, pp. 107-113.
Chen, Shaoqiong et al.; “Wnt-1 Signaling Inhibits Apoptosis by Activating β-Catenin/T Cell Factor-mediated Transcription”; 2001,The Journal of Cell Biology, vol. 152, pp. 87-96.
Herman, James G. et al.; “Gene Silencing in Cancer in Association with Promoter Hypermethylation”; 2003,The New England Journal of Medicine, vol. 349, pp. 2042-2054.
Iiyas, Mohammad; “Wnt signalling and the mechanistic basis of tumour development”; 2005,Journal of Pathology, vol. 205, pp. 130-144.
Mazieres, Julien et al.; “Wnt Inhibitory Factor-1 is Silenced by Promoter Hypermethylation in Human Lung Cancer”; 2004,Cancer Research, vol. 64, pp. 4717-4720.
Ohigashi, T. et al.; “Inhibition of Wnt Signaling Downregulates Akt Activity and Induces Chemosensitivity in PTEN-Mutated Prostate Cancer Cells”; 2005,The Prostate, vol. 62, pp. 61-68.
Reguart, Noemi et al.; “Cloning and characterization of the promoter of human Wnt inhibitory factor-1”; 2004,Biochemical and Biophysical Research Communications, vol. 323, pp. 229-234.
Taniguchi, Hiroaki et al.; “Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers”; 2005,Oncogene, pp. 1-7.
You, Zongbing et al.; “Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis”; 2002,The Journal of Cell Biology, vol. 157, No. 3, pp. 429-440.
Zochbauer-Muller, Sabine et al.; “Aberrant Promoter Methylation of Multiple Genes in Non-Small Cell Lung Cancers”; 2001,Cancer Research, vol. 61, pp. 249-255.
He Biao
Jablons David M.
Xu Zhidong
You Liang
Bozicevic Field & Francis LLP
Goddard Laura B
Rubin Michael B.
The Regents of the University of California
LandOfFree
Methods for treating and diagnosing cancer with WNT... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treating and diagnosing cancer with WNT..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating and diagnosing cancer with WNT... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4082181